axxonis Pharma AG
About us
Projects
Professionals
Patients
Partnership
Contact
Press
 
News axxonis Pharma AG
22. September 2008: axxonis Pharma AG, has identified and patented several new chemical entities as neuroprotective agents

26 June 2008, EMEA Press Release: EMEA recommends new warnings and contraindications for ergot-derived dopamine agonists

Pressemeldung, 4. Juni 2008: Axxonis Pharma AG Berlin hat die europäische Marktzulassung für NenadŽ (Lisurid) als Pflaster und zur subkutanen Infusion beantragt

Press release, 4th June, 2008: Axxonis Pharma AG Berlin submits a European marketing authorisation application for NenadŽ (lisuride) transdermal patch and subcutaneous infusion

December 6th, 2007: Lisuride sc infusion highly effective in reducing severe motor complications in patients with advanced Parkinson´s Disease

Imprint
Disclaimer